| PRMT5 | Protein arginine methyltransferase 5 |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDX | Patient-derived xenograft |
| MRI | Volumetric magnetic resonance imaging |
| I.P. | Intraperitoneal injection |
| S.Q. | Subcutaneous injection |
| P.O. | Per oral administration |
| P.I. | Pancreatic injection |
| S.I. | Splenic injection |
| T.I. | Pancreatic implant of tumor |
| IVIS | In Vivo Imaging Systems |
| Gem | Gemcitabine |
| Ptx | Paclitaxel |
| PRMT5i | PRMT5 inhibitor |
| IHC | Immunohistochemistry |
| γ-H2AX | Phosphorylated gamma-H2AX |
| HPF | High-power fields |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.